1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Pharmaxis Ltd
  6. News
  7. Summary
    PXS   AU000000PXS5

PHARMAXIS LTD

(PXS)
  Report
Delayed Australian Stock Exchange  -  08:06 2022-08-15 pm EDT
0.0780 AUD   +4.00%
08/04Pharmaxis Ltd Announces Resignation of Will Delaat as Non Executive Director
CI
08/04Aptar Pharma Pays Pharmaxis USD 5 Million to Acquire Orbital Technology
CI
07/29Pharmaxis Ltd Reports Earnings Results for the Full Year Ended June 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Pharmaxis Names New Chief Medical Officer

06/30/2022 | 09:07pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
IQVIA HOLDINGS INC. 1.00% 248.26 Delayed Quote.-12.01%
NOVARTIS AG 0.44% 80.45 Delayed Quote.-0.22%
PHARMAXIS LTD 4.00% 0.078 Delayed Quote.-35.00%
All news about PHARMAXIS LTD
08/04Pharmaxis Ltd Announces Resignation of Will Delaat as Non Executive Director
CI
08/04Aptar Pharma Pays Pharmaxis USD 5 Million to Acquire Orbital Technology
CI
07/29Pharmaxis Ltd Reports Earnings Results for the Full Year Ended June 30, 2022
CI
07/29Pharmaxis Ltd Reports Earnings Results for the Fourth Quarter Ended June 30, 2022
CI
07/28TRANSCRIPT : Pharmaxis Ltd, 2022 Earnings Call, Jul 29, 2022
CI
07/10TRANSCRIPT : Pharmaxis Ltd - Shareholder/Analyst Call
CI
06/30Pharmaxis Names New Chief Medical Officer
MT
06/30Pharmaxis Limited Announces the Appointment of Dr. Jana Baskar as Chief Medical Officer
CI
06/14PHARMAXIS : Application for quotation of securities - PXS
PU
05/30PHARMAXIS : Application for quotation of securities - PXS
PU
More news
Financials
Sales 2022 13,0 M 9,15 M 9,15 M
Net income 2022 -16,2 M -11,4 M -11,4 M
Net cash 2022 15,8 M 11,1 M 11,1 M
P/E ratio 2022 -2,50x
Yield 2022 -
Capitalization 41,2 M 29,0 M 29,0 M
EV / Sales 2022 1,95x
EV / Sales 2023 1,33x
Nbr of Employees -
Free-Float 85,8%
Chart PHARMAXIS LTD
Duration : Period :
Pharmaxis Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMAXIS LTD
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,08 AUD
Average target price 0,58 AUD
Spread / Average Target 673%
EPS Revisions
Managers and Directors
Gary Jonathan Phillips Commercial Director
David Morris McGarvey CFO, Secretary & Executive Director
Malcolm John McComas Independent Chairman
Jana Baskar Chief Medical Officer
Kathleen M. Metters Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PHARMAXIS LTD-35.00%30
JOHNSON & JOHNSON-3.37%434 603
ELI LILLY AND COMPANY11.53%292 730
PFIZER, INC.-15.14%281 235
ROCHE HOLDING AG-16.91%275 562
ABBVIE INC.5.32%252 131